Charles Rhyee
Stock Analyst at TD Cowen
(4.19)
# 1,552
Out of 4,673 analysts
654
Total ratings
53.3%
Success rate
5.4%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BTSG BrightSpring Health Services | Reiterated: Buy | $81 | $58.87 | +37.59% | 12 | Aug 19, 2026 | |
| EVH Evolent Health | Rated: Buy | $5 → $6 | $4.74 | +26.58% | 50 | Aug 17, 2026 | |
| CAH Cardinal Health | Rated: Buy | $275 → $280 | $229.51 | +22.00% | 40 | Aug 13, 2026 | |
| DRIO DarioHealth | Rated: Hold | $11 → $8 | $7.49 | +6.81% | 18 | Aug 12, 2026 | |
| GDRX GoodRx Holdings | Rated: Buy | $4 → $5 | $3.45 | +44.93% | 37 | Aug 11, 2026 | |
| CRL Charles River Laboratories International | Rated: Buy | $235 → $300 | $295.19 | +1.63% | 24 | Aug 10, 2026 | |
| CVS CVS Health | Reiterated: Buy | $110 | $93.02 | +18.25% | 59 | Aug 10, 2026 | |
| MDLN Medline | Rated: Buy | $53 → $45 | $34.26 | +31.35% | 5 | Aug 10, 2026 | |
| COR Cencora | Maintained: Buy | $400 | $318.04 | +25.77% | 51 | Aug 9, 2026 | |
| MCK McKesson | Rated: Buy | $989 → $1,006 | $858.90 | +17.13% | 51 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $8 → $12 | $11.90 | +0.84% | 21 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $23 | $18.39 | +25.07% | 16 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $197 | $172.23 | +14.38% | 21 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $6.39 | -6.10% | 59 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $25.01 | +67.93% | 10 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 | $23.70 | -2.95% | 7 | Aug 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $213 → $288 | $259.82 | +10.85% | 25 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $419 → $492 | $620.75 | -20.74% | 15 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $300 → $235 | $247.90 | -5.20% | 20 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.97 | +60.97% | 21 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $338 | $277.51 | +21.80% | 17 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $5.20 | +188.46% | 21 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $27.03 | n/a | 1 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $101.52 | n/a | 1 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $27.80 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $170 | $205.27 | n/a | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.0001 | n/a | 3 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 → $250 | $0.0001 | n/a | 6 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $9 → $1.3 | $0.0001 | n/a | 8 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $370 → $415 | $390.11 | n/a | 6 | Apr 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $360 → $395 | $400.54 | n/a | 5 | Apr 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $29 | $32.04 | n/a | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $74 → $80 | $65.02 | n/a | 4 | Feb 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $410 → $460 | $378.88 | n/a | 7 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $200 → $210 | $200.29 | n/a | 5 | Jun 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $29 | $35.58 | n/a | 4 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $22.22 | n/a | 1 | Feb 25, 2014 |
BrightSpring Health Services
Aug 19, 2026
Reiterated: Buy
Price Target: $81
Current: $58.87
Upside: +37.59%
Evolent Health
Aug 17, 2026
Rated: Buy
Price Target: $5 → $6
Current: $4.74
Upside: +26.58%
Cardinal Health
Aug 13, 2026
Rated: Buy
Price Target: $275 → $280
Current: $229.51
Upside: +22.00%
DarioHealth
Aug 12, 2026
Rated: Hold
Price Target: $11 → $8
Current: $7.49
Upside: +6.81%
GoodRx Holdings
Aug 11, 2026
Rated: Buy
Price Target: $4 → $5
Current: $3.45
Upside: +44.93%
Charles River Laboratories International
Aug 10, 2026
Rated: Buy
Price Target: $235 → $300
Current: $295.19
Upside: +1.63%
CVS Health
Aug 10, 2026
Reiterated: Buy
Price Target: $110
Current: $93.02
Upside: +18.25%
Medline
Aug 10, 2026
Rated: Buy
Price Target: $53 → $45
Current: $34.26
Upside: +31.35%
Cencora
Aug 9, 2026
Maintained: Buy
Price Target: $400
Current: $318.04
Upside: +25.77%
McKesson
Aug 6, 2026
Rated: Buy
Price Target: $989 → $1,006
Current: $858.90
Upside: +17.13%
Aug 5, 2026
Rated: Hold
Price Target: $8 → $12
Current: $11.90
Upside: +0.84%
Aug 4, 2026
Reiterated: Buy
Price Target: $18 → $23
Current: $18.39
Upside: +25.07%
Aug 3, 2026
Rated: Buy
Price Target: $197
Current: $172.23
Upside: +14.38%
Aug 3, 2026
Maintained: Hold
Price Target: $6
Current: $6.39
Upside: -6.10%
Aug 3, 2026
Maintained: Buy
Price Target: $42
Current: $25.01
Upside: +67.93%
Aug 2, 2026
Maintained: Hold
Price Target: $23
Current: $23.70
Upside: -2.95%
Jul 29, 2026
Rated: Buy
Price Target: $213 → $288
Current: $259.82
Upside: +10.85%
Jul 23, 2026
Rated: Hold
Price Target: $419 → $492
Current: $620.75
Upside: -20.74%
Jun 4, 2026
Maintained: Buy
Price Target: $300 → $235
Current: $247.90
Upside: -5.20%
May 27, 2026
Reiterated: Buy
Price Target: $8
Current: $4.97
Upside: +60.97%
May 4, 2026
Rated: Buy
Price Target: $338
Current: $277.51
Upside: +21.80%
Nov 13, 2025
Maintained: Buy
Price Target: $15
Current: $5.20
Upside: +188.46%
Jun 11, 2025
Reiterated: Buy
Price Target: $90
Current: $27.03
Upside: n/a
Jun 5, 2025
Initiated Coverage: Buy
Price Target: $51
Current: $101.52
Upside: n/a
Sep 9, 2024
Reiterated: Buy
Price Target: n/a
Current: $27.80
Upside: n/a
Oct 30, 2023
Maintained: Buy
Price Target: $170
Current: $205.27
Upside: n/a
Dec 12, 2022
Reiterated: Buy
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 16, 2022
Maintained: Buy
Price Target: $2 → $250
Current: $0.0001
Upside: n/a
May 17, 2022
Maintained: Sell
Price Target: $9 → $1.3
Current: $0.0001
Upside: n/a
Apr 16, 2021
Maintained: Buy
Price Target: $370 → $415
Current: $390.11
Upside: n/a
Apr 14, 2021
Maintained: Buy
Price Target: $360 → $395
Current: $400.54
Upside: n/a
Mar 29, 2021
Initiated Coverage: Hold
Price Target: $29
Current: $32.04
Upside: n/a
Feb 8, 2021
Maintained: Buy
Price Target: $74 → $80
Current: $65.02
Upside: n/a
Feb 1, 2021
Maintained: Hold
Price Target: $410 → $460
Current: $378.88
Upside: n/a
Jun 16, 2020
Upgraded: Buy
Price Target: $200 → $210
Current: $200.29
Upside: n/a
Oct 30, 2015
Maintained: Hold
Price Target: $30 → $29
Current: $35.58
Upside: n/a
Feb 25, 2014
Initiated Coverage: Buy
Price Target: $42
Current: $22.22
Upside: n/a